Nasal spray with lower-dose steroid for chronic sinusitis
Treatments studied
Part of Ear, nose & throat clinical trials.
This trial tests a nasal spray called Bactorinol combined with a lower dose of a standard steroid (mometasone) to treat chronic sinusitis. It aims to see if the combination reduces symptoms and is safe and well-tolerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Adults 18 years or older with chronic sinusitis (with or without nasal polyps).
- Your doctor has recommended a steroid nasal spray (mometasone) as part of your treatment.
- Must be able to understand and sign a consent form and attend follow-up visits at the start and at 12 weeks.
- Not pregnant or breastfeeding, free from significant drug or alcohol use, and not have a weakened immune system.
- No known allergy to the ingredients in the study nasal spray.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a nebulized nasal steroid treatment for chronic rhinosinusitis (CRS), which causes long-lasting nasal congestion, runny nose, loss of smell, or facial pain. The treatment goals to reduce symptoms and improve daily comfort.
This study tests a nasal spray made from mastic oil combined with a lower dose of a standard steroid medication (mometasone) for people with chronic sinusitis. It aims to see if this combination is effective in reducing symptoms.
This trial studies whether placing a steroid nasal cream inside your sinus area can reduce symptoms in people with chronic rhinosinusitis (CRS) even after sinus surgery. It may help lower ongoing inflammation and symptoms for those who still feel unwell despite usual medical treatments.
This study tests if a special way of using budesonide (a steroid) as nose drops can improve your sense of smell. It's for people with chronic sinusitis and smell loss, and aims to see if this treatment can help restore some ability to smell.
This trial tests a new nasal spray that combines exosomes (tiny cell messengers), azelastine (an antihistamine), and interferon (a protein that helps fight infections) for people with chronic sinusitis. It aims to reduce symptoms and improve your sinus condition.
This study looks at tissue samples from your nose to understand the inflammation in chronic sinusitis with nasal polyps. It does not test a new drug but may help improve future treatments.
Hear when a new Chronic Rhinosinusitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.